Denosumab is a valuable new option for the treatment of postmenopausal osteoporosis. It is administered once every 6 months via subcutaneous injection, which may be a preferred method of administration.
DENOSUMAB UN NUEVO TRATAMIENTO PARA LA OSTEOPOROSIS QUE SE ADMINISTRA POR VIA SUBCUTANEA CADA 6 MESES
Intra–articular HA or hylan has proven to be an effective, safe, and tolerable treatment for symptomatic knee Osteoarthritis ( Journal of Orthopaedics)
EL ACIDO HIALURONICO ES UN TRATAMIENTO EFECTIVO, SEGURO Y BIEN TOLERADO PARA EL TRATAMIENTO DE LA ARTROSIS DE RODILLA